bisoprolol has been researched along with rivaroxaban in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barake, W; Baranchuk, A; Pinter, A | 1 |
| Kanyal, R; Umeojiako, WI | 1 |
| Akagi, Y; Aoyama, T; Enomoto, A; Hoshiko, M; Kawano, Y; Kujirai, A; Mano, Y; Nagata, M; Nakamatsu, S; Nakamura, S; Negishi, K; Nishikawa, T; Shimada, S; Suzuki, T; Tsukada, E | 1 |
3 other study(ies) available for bisoprolol and rivaroxaban
| Article | Year |
|---|---|
Pseudo-ventricular tachycardia mimicking malignant arrhythmia in a patient with rapid atrial fibrillation.
Topics: Adrenergic beta-1 Receptor Antagonists; Artifacts; Atrial Fibrillation; Bisoprolol; Diagnosis, Differential; Diagnostic Errors; Electrocardiography; Factor Xa Inhibitors; Humans; Male; Middle Aged; Morpholines; Rivaroxaban; Tachycardia, Ventricular; Thiophenes; Treatment Outcome; Unnecessary Procedures | 2014 |
Left ventricular hypertrophy diagnosed after a stroke: a case report.
Topics: Aged, 80 and over; Antihypertensive Agents; Bisoprolol; Cardiomyopathy, Hypertrophic; Chest Pain; Coronary Angiography; Diagnosis, Differential; Dyspnea; Electrocardiography; Factor Xa Inhibitors; Female; Humans; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Rivaroxaban; Stroke; Treatment Outcome | 2018 |
Comprehensive Exploration of Medications That Affect the Bleeding Risk of Oral Anticoagulant Users.
Topics: Administration, Oral; Administrative Claims, Healthcare; Amlodipine; Anticoagulants; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B; Bisoprolol; Case-Control Studies; Drug Interactions; Female; Hemorrhage; Humans; Japan; Male; Middle Aged; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Telmisartan; Warfarin | 2021 |